The annual AdvaMed MedTech Conference, the leading medtech industry conference in North America, will once again bring together over 3,000 attendees from across the world on September 23–25 to network and share insights. GCMI CEO, Tiffany Wilson, is excited to join this group of industry professionals in Boston and to participate in one of the featured sessions at this year’s event.
“We needed to conduct the study perfectly to prove to the FDA that our technology really was safe and effective; we learned that we needed to engage the right partners to do that.” – Innoblative Co-Founder and CEO Tyler Wanke Innoblative seeks to change the game for intraoperative coagulation and ablation of soft tissue via…
At GCMI, medtech and medical device innovation are at the core of our efforts including our work within our industry leading preclinical CRO. While our team constantly focuses on the advancement of our sponsors’ journeys from concept to commercialization to cure, we actively seek to attend events that connect us with medtech innovators across the…